Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177137 · ClinicalTrials.gov registry record · Phase 3
Tinnitus Retraining Therapy Trial
A Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 151
- Enrollment target
NCT01177137 is a Phase 3 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 151 participants.
The verdict
NCT01177137, a Phase 3 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 151 participants
- Enrollment target
Study Summary
The primary purpose of the Tinnitus Retraining Therapy Trial (TRTT) is to assess the efficacy of tinnitus retraining therapy (TRT) as a treatment for severe debilitating tinnitus. TRT is a non-medical intervention that uses directive counseling (DC) and sound therapy (ST)to habituate the patient's associated negative emotional reactions to tinnitus, its perception, and ultimately, its impact on the patient's life.
Interventions
- BEHAVIORAL Standard of Care (SC)
- DEVICE Conventional sound generator (SG)
- DEVICE Placebo sound generator (placebo SG)
- BEHAVIORAL Directive Counseling (DC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01177137
The ClinicalTrials.gov registry entry for NCT01177137 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Standard of Care (SC) is the first listed.
NCT01177137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01177137 about?
NCT01177137 is a clinical study titled "Tinnitus Retraining Therapy Trial". The primary purpose of the Tinnitus Retraining Therapy Trial (TRTT) is to assess the efficacy of tinnitus retraining therapy (TRT) as a treatment for severe debilitating tinnitus. TRT is a non-medical intervention that uses directive counseling (DC) and sound therapy (ST)to habituate the patient's a...
What is the current status of trial NCT01177137?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 151 participants. The study started on 2011-07. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01177137?
The interventions under investigation include: Standard of Care (SC) (BEHAVIORAL), Conventional sound generator (SG) (DEVICE), Placebo sound generator (placebo SG) (DEVICE), Directive Counseling (DC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01177137?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.